Pasar al contenido principal

PROYECTO GEOINF+. ESTUDIO GENETICO DEL IMPACTO DE LA EXPOSICION AMBIENTAL GEOGRAFICA EN MARCADORES INFLAMATORIOS EN POBLACION ADULTA.

PI18/01512

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO INV GERMANS TRIAS I PUJOL
Centro realización INSTITUTO DE INVESTIGACION GERMANS TRIAS I PUJOL (IGTP)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

  • Karachaliou, Marianna|||0000-0002-3014-0747
  • Ranzani, Otavio|||0000-0002-4677-6862
  • Espinosa, Ana|||0000-0001-7399-3267
  • Iraola-Guzmán, Susana|||0000-0003-3359-1241
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Vidal, M.
  • Jiménez, A.
  • Bañuls, Marc
  • Nogués, E.A.
  • Aguilar, R.
  • Garcia-Aymerich, Judith|||0000-0002-7097-4586
  • de Cid, Rafael|||0000-0003-3579-6777
  • Dobaño, C.
  • Moncunill, G.
  • Kogevinas, Manolis|||0000-0002-9605-0461
Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Socioeconomic Inequalities in the External Exposome in European Cohorts, The EXPANSE Project

  • Saucy, Apolline|||0000-0002-6432-2098
  • Coloma, Fabian
  • Olmos, Sergio
  • Åström, Christofer
  • Blay, Natalia|||0000-0002-7160-8529
  • Boer, Jolanda M. A.
  • Dadvand, Payam|||0000-0002-2325-1027
  • De Bont, Jeroen|||0000-0001-9924-5961
  • de Cid, Rafael|||0000-0003-3579-6777
  • de Hoogh, Kees|||0000-0001-5974-2007
  • Dimakopoulou, Konstantina
  • Gehring, Ulrike
  • Huss, Anke
  • Ibi, Dorina
  • Katsouyanni, Klea
  • Koppelman, GGerard
  • Ljungman, Petter
  • Melén, Erik|||0000-0002-8248-0663
  • Nieuwenhuijsen, Mark|||0000-0001-9461-7981
  • Nobile, Federica
  • Peters, Annette|||0000-0001-6645-0985
  • Pickford, Regina
  • Vermeulen, Roel|||0000-0003-4082-8163
  • Vienneau, Danielle
  • Vlaanderen, jelle
  • Wolf, Kathrin
  • Yu, Zhebin
  • Samoli, Evangelia
  • Stafoggia, Massimo
  • Tonne, Cathryn|||0000-0003-3919-8264
Socioeconomic inequalities in the exposome have been found to be complex and highly context-specific, but studies have not been conducted in large population-wide cohorts from multiple countries. This study aims to examine the external exposome, encompassing individual and environmental factors influencing health over the life course, and to perform dimension reduction to derive interpretable characterization of the external exposome for multicountry epidemiological studies. Analyzing data from over 25 million individuals across seven European countries including 12 administrative and traditional cohorts, we utilized domain-specific principal component analysis (PCA) to define the external exposome, focusing on air pollution, the built environment, and air temperature. We conducted linear regression to estimate the association between individual- and area-level socioeconomic position and each domain of the external exposome. Consistent exposure patterns were observed within countries, indicating the representativeness of traditional cohorts for air pollution and the built environment. However, cohorts with limited geographical coverage and Southern European countries displayed lower temperature variability, especially in the cold season, compared to Northern European countries and cohorts including a wide range of urban and rural areas. The individual- and area-level socioeconomic determinants (i.e., education, income, and unemployment rate) of the urban exposome exhibited significant variability across the European region, with area-level indicators showing stronger associations than individual variables. While the PCA approach facilitated common interpretations of the external exposome for air pollution and the built environment, it was less effective for air temperature. The diverse socioeconomic determinants suggest regional variations in environmental health inequities, emphasizing the need for targeted interventions across European countries.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multiomic integration analysis identifies atherogenic metabolites mediating between novel immune genes and cardiovascular risk

  • Carreras-Torres, Robert|||0000-0002-2925-734X
  • Galván-Femenía, Iván|||0000-0002-6124-3730
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Cortés, Beatriz|||0000-0002-2656-7051
  • Díez-Obrero, Virginia|||0000-0002-0163-9872
  • Carreras Nolla, Anna|||0000-0002-8789-067X
  • Moratalla-Navarro, Ferran|||0000-0001-7858-5713
  • Iraola-Guzmán, Susana|||0000-0003-3359-1241
  • Blay, Natalia|||0000-0002-7160-8529
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • de Cid, Rafael|||0000-0003-3579-6777
Background: Understanding genetic-metabolite associations has translational implications for informing cardiovascular risk assessment. Interrogating functional genetic variants enhances our understanding of disease pathogenesis and the development and optimization of targeted interventions. Methods: In this study, a total of 187 plasma metabolite levels were profiled in 4974 individuals of European ancestry of the GCAT| Genomes for Life cohort. Results of genetic analyses were meta-analysed with additional datasets, resulting in up to approximately 40,000 European individuals. Results of meta-analyses were integrated with reference gene expression panels from 58 tissues and cell types to identify predicted gene expression associated with metabolite levels. This approach was also performed for cardiovascular outcomes in three independent large European studies (N = 700,000) to identify predicted gene expression additionally associated with cardiovascular risk. Finally, genetically informed mediation analysis was performed to infer causal mediation in the relationship between gene expression, metabolite levels and cardiovascular risk. Results: A total of 44 genetic loci were associated with 124 metabolites. Lead genetic variants included 11 non-synonymous variants. Predicted expression of 53 fine-mapped genes was associated with 108 metabolite levels; while predicted expression of 6 of these genes was also associated with cardiovascular outcomes, highlighting a new role for regulatory gene HCG27. Additionally, we found that atherogenic metabolite levels mediate the associations between gene expression and cardiovascular risk. Some of these genes showed stronger associations in immune tissues, providing further evidence of the role of immune cells in increasing cardiovascular risk. Conclusions: These findings propose new gene targets that could be potential candidates for drug development aimed at lowering the risk of cardiovascular events through the modulation of blood atherogenic metabolite levels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Machine learning for anxiety and depression profiling and risk assessment in the aftermath of an emergency

  • Villanueva Benito, Guillermo
  • Goldberg, Ximena|||0000-0001-9681-5826
  • Brachowicz, Nicolai
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Blay, Natalia|||0000-0002-7160-8529
  • Espinosa, Ana|||0000-0001-7399-3267
  • Davidhi, Flavia
  • Torres, Diego
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • de Cid, Rafael|||0000-0003-3579-6777
  • Petrone, Paula Marcela
Background & objectives: Mental health disorders pose an increasing public health challenge worsened by the COVID-19 pandemic. The pandemic highlighted gaps in preparedness, emphasizing the need for early identification of at-risk groups and targeted interventions. This study aims to develop a risk assessment tool for anxiety, depression, and self-perceived stress using machine learning (ML) and explainable AI to identify key risk factors and stratify the population into meaningful risk profiles. Methods: We utilized a cohort of 9291 individuals from Northern Spain, with extensive post-COVID-19 mental health surveys. ML classification algorithms predicted depression, anxiety, and self-reported stress in three classes: healthy, mild, and severe outcomes. A novel combination of SHAP (SHapley Additive exPlanations) and UMAP (Uniform Manifold Approximation and Projection) was employed to interpret model predictions and facilitate the identification of high-risk phenotypic clusters. Results: The mean macro-averaged one-vs-one AUROC was 0.77 (± 0.01) for depression, 0.72 (± 0.01) for anxiety, and 0.73 (± 0.02) for self-perceived stress. Key risk factors included poor self-reported health, chronic mental health conditions, and poor social support. High-risk profiles, such as women with reduced sleep hours, were identified for self-perceived stress. Binary classification of healthy vs. at-risk classes yielded F1-Scores over 0.70. Conclusions: Combining SHAP with UMAP for risk profile stratification offers valuable insights for developing effective interventions and shaping public health policies. This data-driven approach to mental health preparedness, when validated in real-world scenarios, can significantly address the mental health impact of public health crises like COVID-19.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex-specific chrono-nutritional patterns and association with body weight in a general population in Spain (GCAT study)

  • Pons-Muzzo, Luciana
  • de Cid, Rafael|||0000-0003-3579-6777
  • Obón-Santacana, Mireia|||0000-0003-4646-3513
  • Straif, Kurt
  • Papantoniou, Kyriaki|||0000-0002-0340-9659
  • Santonja, Isabel|||0000-0002-6736-7988
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Palomar-Cros, Anna|||0000-0001-8151-9290
  • Lassale, Camille|||0000-0002-9340-2708
Background: Altered meal timing patterns can disrupt the circadian system and affect metabolism. Our aim was to describe sex-specific chrono-nutritional patterns, assess their association with body mass index (BMI) and investigate the role of sleep in this relationship. Methods: We used the 2018 questionnaire data from the population-based Genomes for Life (GCAT) (n = 7074) cohort of adults aged 40-65 in Catalonia, Spain, for cross-sectional analysis and its follow-up questionnaire data in 2023 (n = 3128) for longitudinal analysis. We conducted multivariate linear regressions to explore the association between mutually adjusted meal-timing variables (time of first meal, number of eating occasions, nighttime fasting duration) and BMI, accounting for sleep duration and quality, and additional relevant confounders including adherence to a Mediterranean diet. Finally, cluster analysis was performed to identify chrono-nutritional patterns, separately for men and women, and sociodemographic and lifestyle characteristics were compared across clusters and analyzed for associations with BMI. Results: In the cross-sectional analysis, a later time of first meal (β 1 h increase = 0.32, 95% CI 0.18, 0.47) and more eating occasions (only in women, β 1 more eating occasion = 0.25, 95% CI 0.00, 0.51) were associated with a higher BMI, while longer nighttime fasting duration with a lower BMI (β 1 h increase=-0.27, 95% CI -0.41, -0.13). These associations were particularly evident in premenopausal women. Longitudinal analyses corroborated the associations with time of first meal and nighttime fasting duration, particularly in men. Finally, we obtained 3 sex-specific clusters, that mostly differed in number of eating occasions and time of first meal. Clusters defined by a late first meal displayed lower education and higher unemployment in men, as well as higher BMI for both sexes. A clear "breakfast skipping" pattern was identified only in the smallest cluster in men. Conclusions: In a population-based cohort of adults in Catalonia, we found that a later time of first meal was associated with higher BMI, while longer nighttime fasting duration associated with a lower BMI, both in cross-sectional and longitudinal analyses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia

  • Karachaliou, Marianna|||0000-0002-3014-0747
  • Espinosa, Ana|||0000-0001-7399-3267
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Blay, Natalia|||0000-0002-7160-8529
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Iraola-Guzmán, Susana|||0000-0003-3359-1241
  • Rubio, Rocio
  • Vidal, Marta
  • Jiménez, Alfons
  • Bañuls, Marc
  • Aguilar, Ruth|||0000-0003-3277-3107
  • Garcia-Aymerich, Judith|||0000-0002-7097-4586
  • Dobaño Lazaro, Carlota|||0000-0002-6751-4060
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Moncunill, Gemma|||0000-0001-5105-9836
  • de Cid, Rafael|||0000-0003-3579-6777
Background Mental illnesses have been overlooked as a potential factor influencing antibody responses to COVID-19 vaccine. Associations between mental disorders and antibody response might vary by specific disorders, depend on the long-term course of the illness and relate to psychotropic treatment. Methods: The association between mental illness diagnoses (mood affective disorders, anxiety disorders, other) over ten years and psychotropic drug prescription based on electronic health records with antibody levels (IgG and IgA) post COVID-19 vaccination was assessed in 939 vaccinated adults from Catalonia, Spain. We employed linear regression models to assess associations between specific mental illnesses and psychotropic drugs with antibody levels, correcting for demographics, comorbidities and lifestyle factors. In a genotyped subset (n = 247) we assessed the effect of polygenic risk scores (PRS) for mental illnesses and performed a two-sample mendelian randomization (MR) analysis to examine causality between mental illness and antibody responses. Results: Mood affective disorders were associated with lower IgG to receptor binding domain (RBD) [percentage change = -26.37 (95 % CI, -42.00, -6.54)]. Diagnosis of anxiety disorders was not associated with the outcome. The group of other diagnoses (mainly including insomnia and nicotine dependence) were associated with lower IgG RBD levels [percentage change: -21.53 (95 % CI, -35.38, -4.71)] and recent onset cases (≤5 years ago) showed greater decline in antibody levels. Participants on second-generation antipsychotics and multiple classes of psychotropic drugs in the last 6 months exhibited lower antibody levels. In the genotyped population, higher genetic liability (higher PRS) to schizophrenia was associated with lower IgG RBD levels [percentage change = -35.49 (95 % CI, -56.55, -4.23)]. MR analysis revealed a causal relationship between major depression genetic instrumental variables and lower IgG RBD and S levels. Conclusions: These findings raise concerns about the efficacy of COVID-19 vaccines and potentially of other vaccines as well, in individuals with mood affective disorders, current/recent insomnia and nicotine dependence and people on multiple psychotropic drugs. Whether these associations are translated into increased risk for breakthrough infections and immune mediated long-term sequels of the SARS-CoV-2 infection warrants further investigation.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity

  • Tedbury, Philip R.
  • Manfredi, Candela
  • Degenhardt, Frauke
  • Conway, Joseph
  • Horwath, Michael C.
  • McCracken, Courtney
  • Sorscher, Adam J.
  • Moreau, Sandy
  • Wright, Christine
  • Edwards, Carolina
  • Brewer, Jo
  • Guarner, Jeannette
  • Wit, Emmie de
  • Williamson, Brandi N.
  • Suthar, Mehul S.
  • Ong, Yee T.
  • Roback, John D.
  • Alter, David N.
  • Holter, Jan Cato
  • Karlsen, Tom H.
  • Sacchi, Nicoletta
  • Romero-Gómez, Manuel
  • Invernizzi, Pietro
  • Fernández, Javier
  • Buti, María
  • Albillos, Agustín
  • Julià, Antonio
  • Valenti, Luca
  • Asselta, Rosanna
  • Banales, Jesús M.
  • Bujanda, Luis
  • Cid, Rafael de
  • Franke, André
  • Severe COVID-19 GWAS group
  • Horra, Carmen de la
  • Maya-Miles, Douglas
  • Calderón, Enrique J.
  • Medrano, Francisco Javier
  • Ampuero, Javier
  • Martín, Javier
  • Dopazo, Joaquín
  • Delgado, Juan
  • Guerrero, Juan M.
  • Acosta-Herrera, Marialbert
  • Gallego-Durán, Rocío
  • Morilla Romero de la Osa, R.
  • Friaza Patiño, Vicente
  • Sarafianos, Stefan G.
  • Hong, Jeong S.
  • Sorscher, Eric J.
  • Ehrhardt, Annette
Patients with cystic fibrosis (CF) exhibit pronounced respiratory damage and were initially considered among those at highest risk for serious harm from SARS-CoV-2 infection. Numerous clinical studies have subsequently reported that individuals with CF in North America and Europe—while susceptible to severe COVID-19—are often spared from the highest levels of virus-associated mortality. To understand features that might influence COVID-19 among patients with cystic fibrosis, we studied relationships between SARS-CoV-2 and the gene responsible for CF (i.e., the cystic fibrosis transmembrane conductance regulator, CFTR). In contrast to previous reports, we found no association between CFTR carrier status (mutation heterozygosity) and more severe COVID-19 clinical outcomes. We did observe an unexpected trend toward higher mortality among control individuals compared with silent carriers of the common F508del CFTR variant—a finding that will require further study. We next performed experiments to test the influence of homozygous CFTR deficiency on viral propagation and showed that SARS-CoV-2 production in primary airway cells was not altered by the absence of functional CFTR using two independent protocols. On the contrary, experiments performed in vitro strongly indicated that virus proliferation depended on features of the mucosal fluid layer known to be disrupted by absent CFTR in patients with CF, including both low pH and increased viscosity. These results point to the acidic, viscous, and mucus-obstructed airways in patients with cystic fibrosis as unfavorable for the establishment of coronaviral infection. Our findings provide new and important information concerning relationships between the CF clinical phenotype and severity of COVID-19., This work was supported by the Italian Ministry of Health (Ministero della Salute) [Ricerca Finalizzata RF-2016-02364358]; Fondazione IRCCS Ca′ Granda Ospedale Maggiore Policlinico, Ricerca corrente; Fondazione IRCCS Ca′ Granda core COVID-19 Biobank [RC100017A]; “Liver BIBLE” [PR-0391]; and Innovative Medicines Initiative 2 joint undertaking of the European Union (EU) Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations Programme Horizon 2020 [under grant agreement No. 777377] for the project LITMUS and the European Union, programme “Photonics” [under grant agreement 101016726] to LV. JCH was funded by the Research Council of Norway [grant no 312780] and a philanthropic donation from Vivaldi Invest A/S owned by Jon Stephenson von Tetzchner. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report. AF was supported by a grant from the German Federal Ministry of Education and Research [01KI20197]. This work was also funded by a generous philanthropic donation from Banca Intesa San Paolo to RA. This study makes use of data generated by the GCATI Genomes for Life. Cohort study of the Genomes of Catalonia from Institut Germans Trias I Pujol (IGTP); IGTP is part of the CERCA Program/Generalitat de Catalunya. GCAT is supported by Acción de Dinamización del ISCIII-MINECO and the Ministry of Health of the Generalitat of Catalunya [ADE 10/00026], with additional support by the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) [2017-SGR 529], National Grant [PI18/01512], and VEIS project [001-P-001647], co-funded by European Regional Development Fund (ERDF), “A way to build Europe.” EdW and BNW were supported by the Intramural Research Program, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). PRT and SGS received funding from NIH NIAID [R01 AI167356]., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GCAT|Panel, a comprehensive structural variant haplotype map of the Iberian population from high-coverage whole-genome sequencing

  • Valls-Margarit, Jordi|||0000-0002-0766-0349
  • Galván-Femenía, Iván|||0000-0002-6124-3730
  • Matías-Sánchez, Daniel|||0000-0003-4760-6512
  • Blay, Natalia|||0000-0002-7160-8529
  • Puiggròs, Montserrat
  • Carreras Nolla, Anna|||0000-0002-8789-067X
  • Salvoro, Cecilia
  • Cortés, Beatriz|||0000-0002-2656-7051
  • Amela, Ramon
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Lerga Jaso, Jon|||0000-0003-4807-1900
  • Puig Font, Marta|||0000-0002-4439-6372
  • Sánchez Herrero, José Francisco|||0000-0001-6771-4807
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Perucho, Manuel|||0000-0002-2169-2662
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Armengol, Lluís
  • Delaneau, Olivier|||0000-0002-3906-8446
  • Cáceres Aguilar, Mario|||0000-0002-7736-3251
  • de Cid, Rafael|||0000-0003-3579-6777
  • Torrents, David|||0000-0002-6086-9037
The combined analysis of haplotype panels with phenotype clinical cohorts is a common approach to explore the genetic architecture of human diseases. However, genetic studies are mainly based on single nucleotide variants (SNVs) and small insertions and deletions (indels). Here, we contribute to fill this gap by generating a dense haplotype map focused on the identification, characterization, and phasing of structural variants (SVs). By integrating multiple variant identification methods and Logistic Regression Models (LRMs), we present a catalogue of 35 431 441 variants, including 89 178 SVs (≥50 bp), 30 325 064 SNVs and 5 017 199 indels, across 785 Illumina high coverage (30x) whole-genomes from the Iberian GCAT Cohort, containing a median of 3.52M SNVs, 606 336 indels and 6393 SVs per individual. The haplotype panel is able to impute up to 14 360 728 SNVs/indels and 23 179 SVs, showing a 2.7-fold increase for SVs compared with available genetic variation panels. The value of this panel for SVs analysis is shown through an imputed rare Alu element located in a new locus associated with Mononeuritis of lower limb, a rare neuromuscular disease. This study represents the first deep characterization of genetic variation within the Iberian population and the first operational haplotype panel to systematically include the SVs into genome-wide genetic studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biological basis of extensive pleiotropy between blood traits and cancer risk

  • Pardo-Cea, Miguel Ángel|||0000-0003-4823-6613
  • Farré Ramon, Xavier|||0000-0001-6838-9479
  • Esteve, Anna|||0000-0002-1962-971X
  • Palade, Joanna
  • Espín, Roderic
  • Mateo, Francesca|||0000-0002-2342-7010
  • Alsop, Eric
  • Alorda, Marc
  • Blay, Natalia|||0000-0002-7160-8529
  • Baiges, Alexandra
  • Shabbir, Arzoo
  • Comellas, Francesc|||0000-0003-4523-0240
  • Gómez Moruno, Antonio
  • Arnan, Montserrat
  • Teule, Alex|||0000-0003-0028-7200
  • Salinas, Monica
  • Berrocal, Laura
  • Brunet, Joan|||0000-0003-1945-3512
  • Rofes, Paula|||0000-0001-6045-7879
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Conesa, Miquel
  • Rojas, Juan Jose
  • Velten, Lars
  • Fendler, Wojciech
  • Smyczynska, Urszula
  • Chowdhury, Dipanjan
  • Zeng, Yong
  • He, Housheng Hansen
  • Li, Rong
  • Van Keuren-Jensen, Kendall
  • de Cid, Rafael|||0000-0003-3579-6777
  • Pujana, Miguel Angel|||0000-0003-3222-4044
Background: The immune system has a central role in preventing carcinogenesis. Alteration of systemic immune cell levels may increase cancer risk. However, the extent to which common genetic variation influences blood traits and cancer risk remains largely undetermined. Here, we identify pleiotropic variants and predict their underlying molecular and cellular alterations. Methods: Multivariate Cox regression was used to evaluate associations between blood traits and cancer diagnosis in cases in the UK Biobank. Shared genetic variants were identified from the summary statistics of the genome-wide association studies of 27 blood traits and 27 cancer types and subtypes, applying the conditional/conjunctional false-discovery rate approach. Analysis of genomic positions, expression quantitative trait loci, enhancers, regulatory marks, functionally defined gene sets, and bulk- and single-cell expression profiles predicted the biological impact of pleiotropic variants. Plasma small RNAs were sequenced to assess association with cancer diagnosis. Results: The study identified 4093 common genetic variants, involving 1248 gene loci, that contributed to blood-cancer pleiotropism. Genomic hotspots of pleiotropism include chromosomal regions 5p15-TERT and 6p21-HLA. Genes whose products are involved in regulating telomere length are found to be enriched in pleiotropic variants. Pleiotropic gene candidates are frequently linked to transcriptional programs that regulate hematopoiesis and define progenitor cell states of immune system development. Perturbation of the myeloid lineage is indicated by pleiotropic associations with defined master regulators and cell alterations. Eosinophil count is inversely associated with cancer risk. A high frequency of pleiotropic associations is also centered on the regulation of small noncoding Y-RNAs. Predicted pleiotropic Y-RNAs show specific regulatory marks and are overabundant in the normal tissue and blood of cancer patients. Analysis of plasma small RNAs in women who developed breast cancer indicates there is an overabundance of Y-RNA preceding neoplasm diagnosis. Conclusions: This study reveals extensive pleiotropism between blood traits and cancer risk. Pleiotropism is linked to factors and processes involved in hematopoietic development and immune system function, including components of the major histocompatibility complexes, and regulators of telomere length and myeloid lineage. Deregulation of Y-RNAs is also associated with pleiotropism. Overexpression of these elements might indicate increased cancer risk.